币界网报道：Liberty Financial has secured a $100 million investment from Aqua Ventures to expand its Web3 and digital asset services, signaling growing institutional interest in blockchain-based financial solutions. Meanwhile, Synaptogenix, a biotech firm, announced a $100 million investment in TAO Token, aiming to integrate AI and blockchain technologies into its neurodegenerative disease research. The partnership seeks to leverage TAO's decentralized machine learning platform to accelerate drug discovery and data analysis. Both deals highlight the increasing convergence of traditional finance, biotech, and Web3 technologies, with major players allocating significant capital to explore blockchain's potential across industries. The investments come amid a broader trend of institutional adoption, as companies seek to harness decentralized technologies for innovation in their respective fields.